Comments on the Salmeterol Multicenter Asthma Research Trial.
Seymour
Sally M
SM
Sullivan
Eugene J
EJ
Chowdhury
Badrul A
BA
Meyer
Robert J
RJ
Davi
Ruthanna C
RC
D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D000420:Albuterol / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000401:mortality; D064420:Drug-Related Side Effects and Adverse Reactions; D023381:Endpoint Determination; D006801:Humans; D008432:Mathematical Computing; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D015203:Reproducibility of Results; D012307:Risk Factors; D000068299:Salmeterol Xinafoate; D015996:Survival Rate; D014481:United States; D014486:United States Food and Drug Administration
D000318:Adrenergic beta-Agonists; D000068299:Salmeterol Xinafoate; D000420:Albuterol